Speaker illustration

Doctor Ahmed El Amrawy

Faculty of Medicine Alexandria University, Alexandria (Egypt)

Dr. Ahmed El Amrawy is a consultant of interventional cardiology, and a senior lecturer of cardiology in the faculty of medicine in Alexandria university. He is specialized in coronary interventions, intracoronary imaging, and TAVI. His main research areas are related mainly to coronary and structural interventions. He is a board member in Cardioalex annual conference. He speaks English, and Spanish.

Prognostic value of right ventricular diastolic dysfunction in patients with inferior ST elevated myocardial infarction

Event: ESC Congress 2022

Topic: Noninvasive Imaging

Session: Acute coronary syndromes nuts and bolts

Thumbnail

Feasibility and clinical outcomes of 48 mm drug eluting stents in management of patients with coronary artery disease

Event: ESC Congress 2022

Topic: Revascularisation

Session: Coronary artery disease - Revascularisation 4

Thumbnail

Pattern of cardiovascular risk factors and outcomes of patients older than 80 years and presenting with acute coronary syndromes

Event: ESC Congress 2022

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly 2

Thumbnail

Procedural and long-term outcomes of stent post dilatation during primary percutaneous coronary interventions

Event: ESC Congress 2022

Topic: Revascularisation

Session: Revascularisation

Thumbnail

Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome

Event: ESC Congress 2022

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: Approach to acute coronary syndromes

Thumbnail

Moderate intensity exercise training in heart failure with preserved ejection fraction: functional and structural benefits (The MIET-HFpEF trial)

Event: ESC Congress 2021 - The Digital Experience

Topic: Rehabilitation

Session: Chronic heart failure e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb